Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
Top Cited Papers
- 13 April 2005
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (8) , 1295-1301
- https://doi.org/10.1016/j.jacc.2005.01.045
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General PopulationCirculation, 2004
- Inhibition of Clinical Benefits of Aspirin on First Myocardial Infarction by Nonsteroidal Antiinflammatory DrugsCirculation, 2003
- Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: A reappraisalArthritis & Rheumatism, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthaseNature Structural & Molecular Biology, 1995
- Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonistsThe American Journal of Cardiology, 1991
- Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975